2 Einträge von mit access corporate
twitter.com
Datum der Indexierung 06.05.2024 06:27:43
erkannte Namen San Francisco |
Subdomain:
extern (outbound) Link/Domain 14 in .twitter.com
intern (inbound) Link/Domain .twitter.com
Alle Links in alle Links in .twitter.com
HTML Description Twitter Privacy Policy Information You Share With Us
Kombination Keywords your address | information when | twitter have | data public | with share | services from | content about | account this | that privacy | personal other |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
access your account, and address book contacts you’ve uploaded to Twitter. You can also always download the information you have shared on Twitter. In addition to information you share with us, we use your Tweets, content you’ve read, Liked, or Retwe corporate affiliates , and other services you link to your Twitter account. You may choose to connect your Twitter account to accounts on another service, and that other service may send us information about your account on that s
Text Inhalt Text aus URL
Log Metriken 71940
erkannte Namen San Francisco |
Subdomain:
extern (outbound) Link/Domain 14 in .twitter.com
intern (inbound) Link/Domain .twitter.com
Alle Links in alle Links in .twitter.com
HTML Description Twitter Privacy Policy Information You Share With Us
Kombination Keywords your address | information when | twitter have | data public | with share | services from | content about | account this | that privacy | personal other |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
access your account, and address book contacts you’ve uploaded to Twitter. You can also always download the information you have shared on Twitter. In addition to information you share with us, we use your Tweets, content you’ve read, Liked, or Retwe corporate affiliates , and other services you link to your Twitter account. You may choose to connect your Twitter account to accounts on another service, and that other service may send us information about your account on that s
Text Inhalt Text aus URL
Log Metriken 71940
www.cslbehring.ch
Datum der Indexierung 04.10.2024 23:31:04
erkannte Namen Gene Therapy | Emmanuelle Lecomte | Isabelle Dahinden | Maria Tortoreto | Asia Pacific |
weitere Namen in www.cslbehring.ch 5
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Swissmedic Approval for HEMGENIX®
Kombination Keywords patients rare | hemgenix this | factor from | hemophilia people | with gene | treatment disease | that therapy | behring your | bleeding more | switzerland global |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
access to this innovative treatment option,” said Dr. Isabelle Dahinden, General Manager Switzerland, CSL Behring. “We are proud to add this treatment to our portfolio of coagulation therapies and look forward to patients benefiting from this therapy Corporate Message 15 Jan 2024 Story Bern, Switzerland – 15 January 2024 – Global biotechnology leader CSL (ASX: CSL) announced today that Swissmedic has authorised HEMGENIX® (etranacogene dezaparvovec), the first and currently onl
Text Inhalt Text aus URL
Log Metriken 86111
erkannte Namen Gene Therapy | Emmanuelle Lecomte | Isabelle Dahinden | Maria Tortoreto | Asia Pacific |
weitere Namen in www.cslbehring.ch 5
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Swissmedic Approval for HEMGENIX®
Kombination Keywords patients rare | hemgenix this | factor from | hemophilia people | with gene | treatment disease | that therapy | behring your | bleeding more | switzerland global |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
access to this innovative treatment option,” said Dr. Isabelle Dahinden, General Manager Switzerland, CSL Behring. “We are proud to add this treatment to our portfolio of coagulation therapies and look forward to patients benefiting from this therapy Corporate Message 15 Jan 2024 Story Bern, Switzerland – 15 January 2024 – Global biotechnology leader CSL (ASX: CSL) announced today that Swissmedic has authorised HEMGENIX® (etranacogene dezaparvovec), the first and currently onl
Text Inhalt Text aus URL
Log Metriken 86111